Industry ranking
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Oct 2025 - 31 Mar 2026 | 29 Apr 2026 | 38 | 28% | 66% | 6% | 14% |
| 01 Apr 2025 - 30 Sept 2025 | 29 Oct 2025 | 36 | 55% | 45% | 0% | 10% |
| 01 Oct 2024 - 31 Mar 2025 | 30 Apr 2025 | 38 | 32% | 62% | 6% | 11% |
| 01 Apr 2024 - 30 Sept 2024 | 28 Oct 2024 | 41 | 25% | 69% | 6% | 14% |
| 01 Oct 2023 - 31 Mar 2024 | 28 Oct 2024 | 59 | 21% | 65% | 14% | 23% |
| 01 Apr 2023 - 30 Sept 2023 | 28 Oct 2024 | 79 | 16% | 54% | 30% | 45% |
| 01 Oct 2022 - 31 Mar 2023 | 28 Apr 2023 | 73 | 26% | 49% | 25% | 40% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
Our standard payment terms are 45 days from date of invoice. These may be varied on a case by case basis.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
59
We refer to the contract between parties as a starting point, and if there are specific issues and challenges then we will engage in a discussion to find a pragmatic way forward.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Cancer Research Technology Limited now trades as Cancer Research Horizons. It is a wholly owned subsidiary of Cancer Research UK, acting as its translational arm to move scientific discoveries from the laboratory towards patients. It describes itself as a specialist drug discovery, development and commercialisation company, working across target identification, hit identification, lead optimisation and candidate selection for small molecule and antibody treatments. It licenses innovations, supports start-ups, and partners with industry, investors and researchers to bring new cancer treatments and diagnostics to market, drawing on Cancer Research UK's research network and operating drug discovery activity across several UK sites.
Generated from the company's website and Companies House records. Sources: commercial.cancerresearchuk.org · commercial.cancerresearchuk.org